Data Needs in Oncology: “Making Sense of The Big Data Soup”

Restricted access

Rising health care costs and continued concerns about safety, efficacy, and quality have resulted in the demand for more data and evidence by payors, regulators, providers, and patients alike. Stakeholders with different objectives for the use of data are driving the need for more and “better” data. It is important for organizations to not only understand how to handle and collect data but also translate it into actionable information that can help transform health care delivery. Appropriate use of data can lead to reduced health care costs and increased value to all stakeholders. In June 2012, NCCN assembled a work group composed of thought leaders from NCCN Member Institutions and other organizations to identify and examine the challenges of data generation, collection, and application for clinical, regulatory, and coverage decision-making. The NCCN Data Needs Work Group identified 4 main areas for consideration: data sources, patient-derived data, payor-collected data, and regulatory policy toward data generation and use.

  • 1.

    Arnould B, Caron M, Emery MP. Do patient-reported outcomes contribute to regulatory decisions in the USA and Europe? A systematic review of guidance documents and authorizations of medicinal products from 2006 to 2010. Available at: https://smdm.confex.com/smdm/2011ch/webprogram/Paper6550.html. Accessed March 21, 2013.

    • Search Google Scholar
    • Export Citation
  • 2.

    Garcia SF, Cella D, Clauser SB. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol 2007;25:51065112.

    • Search Google Scholar
    • Export Citation
  • 3.

    Hershman DL, Wright JD. Comparative effectiveness in oncology methodology: observation data. J Clin Oncol 2012;30:42154222.

  • 4.

    National Program of Cancer Registries Web site. About the program. Available at: http://www.cdc.gov/cancer/npcr/about.htm. Accessed March 21, 2013.

    • Search Google Scholar
    • Export Citation
  • 5.

    Surveillance, Epidemiology, and End Results Web site. Overview of the SEER program. Available at: http://seer.cancer.gov/about/overview.html. Accessed March 21, 2013.

    • Search Google Scholar
    • Export Citation
  • 6.

    American College of Surgeons Web site. National Cancer Data Base. Available at: http://www.facs.org/cancer/ncdb/index.html. Accessed March 21, 2013.

    • Search Google Scholar
    • Export Citation
  • 7.

    Bhattacharjee Y. Pharma firms push for sharing of cancer trial data. Science 2012;338:29.

  • 8.

    FierceMarkets PharmaTech Web site. 10 pharma giants form nonprofit to gang up on common R&D foes. Available at: http://www.fiercebiotech.com/story/10-pharma-giants-form-nonprofit-gang-common-rd-foes/2012-09-19. Accessed March 21, 2013.

    • Search Google Scholar
    • Export Citation
  • 9.

    Handler J, Holtmeier R, Metzger J. HIMSS electronic health record definition model Version 1.0. Available at: http://www.pranagy.com/uploads/HIMSS_EMR_Definition_Model_v1-0.pdf. Accessed March 21, 2013.

    • Search Google Scholar
    • Export Citation
  • 10.

    Dean BB, Lam J, Natoli JL. Use of electronic medical records for health outcomes research: a literature review. Med Care Res Rev 2010;66:611638.

    • Search Google Scholar
    • Export Citation
  • 11.

    Clinical Oncology Requirements for the EHR. Available at: http://www.asco.org/ASCOv2/Department%20Content/Cancer%20Policy%20and%20Clinical%20Affairs/CORE%20white%20paper%20100609.pdf. Accessed March 21, 2013.

    • Search Google Scholar
    • Export Citation
  • 12.

    Yu PP. The evolution of oncology electronic health records. Cancer J 2011;17:197202.

  • 13.

    Hsiao CJ, Hing E. Use and characteristics of electronic health record systems among office-based physician practices: United States 2001-2012. NCHS Data Brief 2012;(111):18.

    • Search Google Scholar
    • Export Citation
  • 14.

    Leonard D, Tozzi J. Why don’t more hospitals use electronic health records? Available at: http://www.businessweek.com/articles/2012-06-21/why-dont-more-hospitals-use-electronic-health-records. Accessed March 26, 2013.

    • Search Google Scholar
    • Export Citation
  • 15.

    Miriovsky BJ, Shulman LN, Abernethy AP. Importance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care. J Clin Oncol 2012;30:42434248.

    • Search Google Scholar
    • Export Citation
  • 16.

    Lowes R. Fear of data theft blunts public acceptance of EHRs. Available at: http://www.medscape.com/viewarticle/769778. Accessed August 27, 2012.

    • Search Google Scholar
    • Export Citation
  • 17.

    Lipscomb J, Gotay CC, Snyder CF. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 2007;57:278300.

    • Search Google Scholar
    • Export Citation
  • 18.

    Ganz PA, Goodwin PJ. Quality of life in breast cancer: what have we learned and where do we go from here. In: Lipscomb J, Gotay CC, Snyder C, eds. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge, UK: Cambridge University Press; 2005:93126.

    • Search Google Scholar
    • Export Citation
  • 19.

    Litwin MS, Talcott JA. Measuring quality of life in prostate cancer: progress and challenges. In: Lipscomb J, Gotay CC, Snyder C, eds. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge, UK: Cambridge University Press; 2005:160178.

    • Search Google Scholar
    • Export Citation
  • 20.

    U.S. Food and Drug Administration Web site. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed March 26, 2013.

    • Search Google Scholar
    • Export Citation
  • 21.

    Center for Medical Technology Policy Web site. Recommendations for Incorporating Patient-Reported Outcomes into the Design of Clinical Trials in Adult Oncology. Available at: http://www.cmtpnet.org/wp-content/uploads/downloads/2012/05/PRO-EGD.pdf. Accessed March 26, 2013.

    • Search Google Scholar
    • Export Citation
  • 22.

    Clinical Data Interchange Standards Consortium Web site. Mission & Principles. Available at: http://www.cdisc.org/mission-and-principles. Accessed March 26, 2013.

    • Search Google Scholar
    • Export Citation
  • 23.

    Draft revision of guidance for industry on providing regulatory submissions in electronic format—certain human pharmaceutical product applications and related submissions using the electronic common technical document specifications; availability. Fed Regist 2013;78:310311

    • Search Google Scholar
    • Export Citation
  • 24.

    U.S. Food and Drug Administration Web site. Janus Clinical Trials Repository Project. Available at: http://www.fda.gov/ForIndustry/DataStandards/StudyDataStandards/ucm155327.htm. Accessed March 26, 2013.

    • Search Google Scholar
    • Export Citation
  • 25.

    U.S. Food and Drug Administration Web site. Guidance for Industry. Electronic Source Data in Clinical Investigations. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM328691.pdf. Accessed March 26, 2013.

    • Search Google Scholar
    • Export Citation
  • 26.

    Sandburg B. Clinical Trial Regs: FDA Seeks Advice On How to Make Them Better, Faster, Stronger. The Pink Sheet, Vol. 74, No. 13, March 26, 2012.

    • Search Google Scholar
    • Export Citation
  • 27.

    Kelly C. “Blossoming” Evidence Demands For Drugs A Burden on Innovation, Pfizer Exec Says. The Pink Sheet, Vol. 74, No. 14, April 2, 2012.

    • Search Google Scholar
    • Export Citation
  • 28.

    Young RA, DeVoe JE. Who will have health insurance in the future? An updated projection. Ann Fam Med 2012;10:156162.

  • 29.

    Tunis SR, Pearson SD. Coverage options for promising technologies: Medicare’s ‘coverage with evidence development’. Health Aff (Millwood) 2006;25:12181230.

    • Search Google Scholar
    • Export Citation
  • 30.

    Hillner BE, Siegel BA, Liu D. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the national oncologic PET registry. J Clin Oncol 2008;26:21552161.

    • Search Google Scholar
    • Export Citation
  • 31.

    Carino T, Williams RD II, Colbert AM, Bridger P. Medicare’s coverage of colorectal cancer drugs: a case study in evidence development and policy. Health Aff (Millwood) 2006;25:12311239.

    • Search Google Scholar
    • Export Citation
  • 32.

    Nass SJ, Wizemann T. National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine. Informatics Needs and Challenges in Cancer Research: Workshop Summary. Washington, DC: The National Academies Press; 2012.

    • Search Google Scholar
    • Export Citation
  • 33.

    Kean MA, Abernethy AP, Clark AM. Achieving data liquidity in the cancer community: proposal for a coalition of all stakeholders. Washington, DC: Institute of Medicine of the National Academies; 2012. Available at: http://www.iom.edu/~/media/Files/Perspectives-Files/2012/Discussion-Papers/NCPF-Achieving-Data-Liquidity.pdf. Accessed March 26, 2013.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 360 209 5
PDF Downloads 52 26 0
EPUB Downloads 0 0 0